Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

RTA 408 cream protects mice from radiation skin damage.

Intradermal testing can better detect corticosteroid allergies than patch testing.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

New therapies for rare skin diseases show promise but need more research.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Atopy and altered T cell functions contribute to Alopecia Areata.

Retinoids might cause temporary hyperthyroidism in some patients.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.